By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics today priced its initial public offering at $9 per share, below the $12 to $14 range the company had earlier projected.

The shares are expected to begin trading on the Nasdaq Global Market today under ticker symbol "GNOM."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.